Data on sprytne.com is aggregated from official U.S. Government sources including the SEC EDGAR database, USAspending.gov, USPTO, and U.S. Census Bureau. In accordance with 17 U.S.C. § 105, works of the U.S. Government are not subject to copyright protection and reside in the Public Domain. sprytne.com provides value-added visualization and algorithmic analysis of these public records.
Not financial advice. sprytne.com is an automated market intelligence platform. We are not a registered investment advisor, broker, or dealer. Financial metrics, risk scores, and federal award data are for informational purposes only. Past performance (including government contract history) is not indicative of future market results. Verify all data via official SEC.gov filings.
This platform adheres to CCPA/GDPR standards regarding professional and public business data. Information displayed pertains to commercial entities and public officers in their professional capacity. For data verification or removal requests regarding non-public information, please visit our Contact page. Operated under Brand House Data Systems framework.
© 2026 sprytne.com — Institutional Data Intelligence — Federal Transparency Initiative
Top in vitro & in vivo diagnostic substances companies in Delaware, ranked by financial performance.
Delaware Sector Intelligence · Sprytne.com
In Delaware, the in vitro & in vivo diagnostic substances sector is led by IDEXX LABORATORIES INC /DE (IDXX) with $4.30B in annual revenue. The fastest-growing player is Intellia Therapeutics, Inc. at +16.9% YoY growth.
Based on the latest SEC EDGAR 10-K annual filings · Verified public data
| Rank | Company | Revenue | Details |
|---|---|---|---|
| #1 | IDEXX LABORATORIES INC /DEIDXX | $4.30B | YoY: +10.4% |
| #2 | Lantheus Holdings, Inc.LNTH | $1.54B | YoY: +0.5% |
| #3 | MYRIAD GENETICS INCMYGN | $824.5M | YoY: -1.6% |
| #4 | Intellia Therapeutics, Inc.NTLA | $67.7M | YoY: +16.9% |
| #5 | Alpha Teknova, Inc.TKNO | $40.5M | YoY: +7.4% |
| #6 | IMMUCELL CORP /DE/ICCC | $17.5M | YoY: -5.9% |
| #7 | Aspira Women's Health Inc.AWHL | $9.2M | YoY: +0.3% |
| #8 | BIOMERICA INCBMRA | $5.3M | YoY: -1.9% |
| #9 | Q/C TECHNOLOGIES, INC.QCLS | $1.6M | YoY: -5.3% |
| #10 | Celldex Therapeutics, Inc.CLDX | $1.5M | YoY: -78.0% |
| #11 | VOLITIONRX LTDVNRX | $1.2M | YoY: +59.1% |
| #12 | Cardio Diagnostics Holdings, Inc.CDIO | $14,825 | YoY: -57.5% |
| Rank | Company | YoY Growth | Details |
|---|---|---|---|
| #1 | Intellia Therapeutics, Inc.NTLA | +16.9% | Revenue: $67.7M |
| #2 | IDEXX LABORATORIES INC /DEIDXX | +10.4% | Revenue: $4.30B |
| #3 | Alpha Teknova, Inc.TKNO | +7.4% | Revenue: $40.5M |
| #4 | Lantheus Holdings, Inc.LNTH | +0.5% | Revenue: $1.54B |
| Rank | Company | Net Income | Details |
|---|---|---|---|
| #1 | IDEXX LABORATORIES INC /DEIDXX | $1.06B | Margin: 24.6% |
| #2 | Lantheus Holdings, Inc.LNTH | $233.6M | Margin: 15.2% |